Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated Jul 2, 2018 (8 years ago)

Piperacillin and Tazobactam for Injection USP 3.375 grams per vial

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Presence of Particulate Matter: identified as glass and silicone material

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Piperacillin and Tazobactam for Injection USP 3.375 grams per vial, Single-Dose Vial, Rx Only. Manufactured for: Auromedics Pharma LLC 6 Wheeling Road Dayton NJ 08810, Made in India. NDC 55150-120-30

Affected NDC 55150-0120-30

Compare with the code on your package — it is the most precise check available.

Drug: Tazobactam

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Piperacillin and Tazobactam
Piperacillin Sodium and Tazobactam Sodium
NDC 55150-0120
PIPERACILLIN SODIUM 3 g/1; TAZOBACTAM SODIUM .375 g/1 Injection, Powder, Lyophilized, for Solution
Intravenous
Eugia US LLC Rx
Recalling firm
AuroMedics Pharma LLC
NDC code
55150-120-30
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1030-2018 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Tazobactam recalls

See all

Other recalls by AuroMedics Pharma LLC

All 2018 recalls
Class II · Moderate risk

Acyclovir Sodium Injection

Presence of Particulate Matter: Customer complaint for a dark red, brown and black particulate floating inside vial.

Completed Particulate / foreign matter AuroMedics Pharma LLC NDC 55150-154-10 D-0013-2023